Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Advanced search

Search projects and results

Results 1 - 5 of 5
Order by: Results/page:
1
Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome
ID: 755225
Start date: 2018-01-01, End date: 2022-12-31
Crigler-Najjar syndrome (CN) is a rare recessive disorder caused by mutations in the uridine diphosphate glucuronosyltransferase 1A1(UGT1A1) gene. CN is a life-threatening disease with no cure which constitutes a severe burden for the patients, their families, and the society...
Programme: H2020-EU.3.1.3.
Record Number: 212689
Last updated on: 2018-01-23
A global alliance for Zika virus control and prevention
ID: 734548
Start date: 2016-10-01, End date: 2019-09-30
"ZIKAlliance is a multidisciplinary project with a global ""One Health"" approach, built: on a multi-centric network of clinical cohorts in the Caribbean, Central & South America; research sites in countries where the virus has been or is currently circulating (Africa, Asia...
Programme: H2020-EU.3.1.3.
Record Number: 207455
Last updated on: 2017-08-23
Clinical Proof of concept for a RNA-targeting Oligonucleotide for a Cystic fibrosis-F508del MEDication
ID: 633545
Start date: 2015-05-01, End date: 2017-12-31
Cystic fibrosis (CF) is a progressive life-shortening disease caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene leading to a dysfunctional CFTR protein. The disease affects over 70,000 patients worldwide and while many mutations are...
Programme: H2020-EU.3.1.3.
Record Number: 193242
Last updated on: 2017-08-22
GlucoCEST Imaging of Neoplastic Tumours
ID: 667510
Start date: 2016-01-01, End date: 2019-12-31
Cancer is one of the most devastating diseases the world is currently facing, accounting for 7.6 million deaths in 2008 (WHO). Cancer is usually detected through advanced medical imaging. Early detection is very important as it increases the chances of survival and the...
Programme: H2020-EU.3.1.3.
Record Number: 199734
Last updated on: 2017-07-14
Development of an innovative gene therapy platform to cure rare hereditary muscle disorders
ID: 667751
Start date: 2016-01-01, End date: 2019-12-31
The objective of MYOCURE is to develop an innovative gene therapy platform to cure rare hereditary muscle disorders, specifically focusing on myotubular myopathy (MTM) and glycogen storage disorder (GSD) type II. These are attractive diseases for gene therapy since they...
Programme: H2020-EU.3.1.3.
Record Number: 199738
Last updated on: 2016-11-29
List retrieved on: 2018-11-15
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top